| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/27/2013 | CN102940648A Bee propolis soft capsule and manufacturing process thereof |
| 02/27/2013 | CN102940644A Drug for treating nasosinusitis |
| 02/27/2013 | CN102940642A Aspirin eugenol ester-paracetamol compound sustained-release tablet |
| 02/27/2013 | CN102940641A Formula of medicament for treating beriberi |
| 02/27/2013 | CN102940637A Isoniazid-rifampicin-anethol trithione composition and its oral preparation |
| 02/27/2013 | CN102940636A Injection of piperacillin-sulbactum sodium medicine composition and preparation method thereof |
| 02/27/2013 | CN102940634A Isoniazid-anethol trithione composition and its oral preparation |
| 02/27/2013 | CN102940632A Application of FK506-A compound in preparation of immunosuppressant |
| 02/27/2013 | CN102940630A Medicinal composition containing temsirolimus and preparation method of medicinal composition |
| 02/27/2013 | CN102940626A Applications of Eryngiolide A in anti-herpes virus drugs |
| 02/27/2013 | CN102940615A Erythromycin enteric-coated tablets and preparation method thereof |
| 02/27/2013 | CN102940612A Method for preparing norfloxacin tablets |
| 02/27/2013 | CN102940607A Injection of piperacillin-sulbactum sodium medicine composition injection and preparation method thereof |
| 02/27/2013 | CN102940595A Mouthwash with functions of antibiosis, antiphlogosis and deodorization, and preparation method and use thereof |
| 02/27/2013 | CN102940468A Traditional Chinese medicine wet wipe |
| 02/27/2013 | CN102939976A Disinfection isolating agent for silkworm bodies and silkworm rearing beds of silkworm breeding with artificial diet and application thereof |
| 02/27/2013 | CN102351859B Antibiotic Pseudonocardian A and Pseudonocardian B, its preparation method thereof and its application in preparation of antibiotics and antitumor drug |
| 02/27/2013 | CN102268410B Newcastle disease virus heat-resistant attenuated strain adapted to baby hamster kidney passage cell and preparation method and application thereof |
| 02/27/2013 | CN102250843B Genetic engineering marked attenuated vaccine strain of porcine reproductive and respiratory syndrome virus and application thereof |
| 02/27/2013 | CN102247600B Method for preparing diluent for pseudorabies live vaccine |
| 02/27/2013 | CN102229932B Nucleic acid aptamer capable of identifying HCV E1E2 (hepatitis C virus E1E2), nucleic acid aptamer derivatives and screening method and application thereof |
| 02/27/2013 | CN102218048B Application of magnolol in preparation of external preparations and daily chemical products for treating dermatosis caused by malassezia |
| 02/27/2013 | CN102210737B Sweet potato leaf extract and preparation method and use thereof |
| 02/27/2013 | CN102204914B Use of 4-alkyl-6-aryl-5-acetyl-1,3-thiazine for preparing neuraminidase inhibitor |
| 02/27/2013 | CN102198091B Acupuncture point injection |
| 02/27/2013 | CN102154219B Swine influenza A H1N1 virus and use thereof |
| 02/27/2013 | CN102153533B 3-nitro-2H-chromene compounds with antibacterial activity and preparation method and application thereof |
| 02/27/2013 | CN101947323B Gram negative bacterium vaccine and preparation method thereof |
| 02/27/2013 | CN101928246B N-[(1-aryl-3-substituted phenyl-pyrazol-4-yl) methenyl]-2-hydroxyl benzoyl hydrazine compound or pharmaceutically acceptable salts and preparation method thereof |
| 02/27/2013 | CN101918410B Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 02/27/2013 | CN101790533B Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 02/27/2013 | CN101748078B Novel Bacillus amyloliquefaciens strain and application thereof |
| 02/27/2013 | CN101732467B Application of Chinese medicinal composition in preparation of medicament for treating purulent pleurisy |
| 02/27/2013 | CN101626762B Solvating system and sealant for medical use |
| 02/27/2013 | CN101613398B Surface lipoprotein of streptococcus suis type-2, preparation method thereof and application |
| 02/27/2013 | CN101220370B Bifidobacteria-bacillus coli shuttle expression vector, preparation method and application thereof |
| 02/26/2013 | US8383824 Heterocyclic antiviral compounds |
| 02/26/2013 | US8383804 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof |
| 02/26/2013 | US8383790 Modified surface antigen |
| 02/26/2013 | US8383665 Immunomodulatory compositions |
| 02/26/2013 | US8383634 Methods of treatment using heteroaryl compounds and compositions thereof |
| 02/26/2013 | US8383582 Inhibitor against forming biofilm comprising κ-casein macropeptide |
| 02/26/2013 | US8383333 HBV precore protein capable of forming particles |
| 02/26/2013 | US8383170 Mucosal formulation |
| 02/26/2013 | US8383164 Antiviral composition and method for using the same |
| 02/26/2013 | US8383153 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 02/26/2013 | US8383126 Bacterial pheromones and uses thereof |
| 02/26/2013 | US8383110 Modulators of Candida hyphal morphogenesis and uses thereof |
| 02/26/2013 | US8383101 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 02/26/2013 | CA2617659C Use of hydroxybenzoic acid esters and analogues for the manufacture of a medicament for the prevention and treatment of virus infection |
| 02/26/2013 | CA2608468C Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 02/26/2013 | CA2564546C Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 02/26/2013 | CA2493406C Gm-negative ehv-mutants without heterologous elements |
| 02/26/2013 | CA2492068C Assays for assembly of ebola virus nucleocapsids |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/26/2013 | CA2430115C Recombinant rsv virus expression systems and vaccines |
| 02/26/2013 | CA2358570C Protonated/acidified nucleic acids and methods of use |
| 02/21/2013 | WO2013025834A2 Compositions and methods related to antibodies to staphylococcal protein a |
| 02/21/2013 | WO2013025788A1 Tenofovir alafenamide hemifumarate |
| 02/21/2013 | WO2013025584A1 Inhibitors of human immunodeficiency virus replication |
| 02/21/2013 | WO2013025479A1 Jaml specific binding agents, antibodies, and uses related thereto |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024859A1 Molecular mimic mucosal aids vaccine |
| 02/21/2013 | WO2013024589A1 Prophylactic agent and/or therapeutic agent for sepsis |
| 02/21/2013 | WO2013024493A1 C-9 oxygen functionalized labdane derivates |
| 02/21/2013 | WO2013024157A2 Combinations of host targeting agents for the treatment and the prevention of hcv infection |
| 02/21/2013 | WO2013024156A2 Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection |
| 02/21/2013 | WO2013024155A1 Combinations of anti-hcv-entry factor antibodies and direct acting antivirals for the treatment and the prevention of hcv infection |
| 02/21/2013 | WO2013023362A1 Cytomegalovirus human immunoglobulin for intravenous injection, and preparation method therefor |
| 02/21/2013 | WO2013023340A1 Honeysuckle extract, and pharmaceutical composition comprising the same and use of the same |
| 02/21/2013 | WO2013023339A1 Secologanolic acid, pharmaceutical composition comprising same and use thereof |
| 02/21/2013 | WO2013023338A1 Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug |
| 02/21/2013 | WO2012177660A3 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/21/2013 | WO2012166716A3 Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections |
| 02/21/2013 | WO2012154271A3 Method and cells for identifying rig-i pathway regulators |
| 02/21/2013 | WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors |
| 02/21/2013 | US20130046260 Disinfecting wound dressing and process for preparing such |
| 02/21/2013 | US20130046240 Bepotastine compositions |
| 02/21/2013 | US20130046019 Methods of Treatment Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production |
| 02/21/2013 | US20130046005 Treatment of immune disorders using kainate receptor antagonists |
| 02/21/2013 | US20130045999 Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045991 Neuroprotective modulation of nmda receptor subtype activities |
| 02/21/2013 | US20130045962 Peptide deformylase inhibitors |
| 02/21/2013 | US20130045955 Novel compounds |
| 02/21/2013 | US20130045950 Phosphonate Compounds |
| 02/21/2013 | US20130045946 Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved |
| 02/21/2013 | US20130045941 Dimethyl sulfoxide (dmso) or dmso and methylsulfonylmethane (msm) formulations to treat infectious diseases |
| 02/21/2013 | US20130045937 Parenteral formulations of macrolide antibiotics |
| 02/21/2013 | US20130045932 Retinoid topical compositions and methods for treating skin conditions |
| 02/21/2013 | US20130045931 Production and use of antibacterial, antiproliferative, and antiphytopathogenic benzanthracenes |
| 02/21/2013 | US20130045520 Double-stranded oligonucleotides |
| 02/21/2013 | US20130045280 Product and treatment for hepatitis c and sclerosis of the liver and methods of forming the product |
| 02/21/2013 | US20130045274 Bacteriotherapy for clostridium difficile colitis |
| 02/21/2013 | US20130045270 Method of use of stabilized growth factor in skin care |
| 02/21/2013 | US20130045267 Methods of using agents that modulate claudin expression |
| 02/21/2013 | US20130045266 Method for preparing polymeric biomaterials having immobilized drug delivery system comprising bioactive molecules loaded particle carrier |
| 02/21/2013 | US20130045243 NANOGENOMICS FOR MEDICINE: siRNA ENGINEERING |
| 02/21/2013 | US20130045237 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| 02/21/2013 | US20130045231 Immunogenic composition |